Skip to search
Skip to main content
Back to Search
Start Over
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis
Authors :
Projectafdeling ALS Neurologen Brain Regenerative Medicine and Stem Cells Weemering, Daphne N Midei, Mark Milner, Peter Gopalakrishnan, Vidhya Kumar, Anil Dannenberg, Andrew J Bunte, Tommy M Foucher, Juliette Ingre, Caroline Ķēniņa, Viktorija Rallmann, Karin van den Berg, Leonard H van Eijk, Ruben P A Projectafdeling ALS Neurologen Brain Regenerative Medicine and Stem Cells Weemering, Daphne N Midei, Mark Milner, Peter Gopalakrishnan, Vidhya Kumar, Anil Dannenberg, Andrew J Bunte, Tommy M Foucher, Juliette Ingre, Caroline Ķēniņa, Viktorija Rallmann, Karin van den Berg, Leonard H van Eijk, Ruben P A
Publication Year :
2023
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1432122514
Document Type :
Electronic Resource